TP53 and cancer: Outcome revealed that the 29 selected DEGs were evidently enriched in the p53 signaling pathway, pathways in cancer, oocyte meiosis, and prostate cancer (P < 0.05, Supplementary Tables 4 and 5 and Fig. 5).